In a notable phase II clinical trial published in The Lancet (2008), Tesofensine demonstrated dose-dependent weight loss of up to 10.6% over 24 weeks in obese individualssubstantially higher than placebo or many existing weight-loss drugs
By directly targeting fat deposits and optimizing liver function, these injections provide a dual-action approach to weight management and vitality
However, no supplement or compound is a substitute for a tailored, comprehensive approach
There is no set timescale as we are all different
The behaviour of the final solution also depends on the peptides purity, salt form, residual solvents, counterions, lyophilisation quality, moisture exposure, storage history, excipients, sequence length, hydrophobicity, and pH profile
For both Ozempic and Wegovy , the expiration date is 24 months from the date of manufacture as long as the medication is refrigerated (36F46F)